- Trials with a EudraCT protocol (11)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (16)
11 result(s) found for: Kv.
Displaying page 1 of 1.
EudraCT Number: 2011-000105-53 | Sponsor Protocol Number: 17P-FU-004 | Start Date*: 2011-04-20 |
Sponsor Name:Hologic, Inc. | ||
Full Title: Estudio prospectivo, de seguimiento, de niños de 23 a 25 meses, nacidos de madres que recibieron Caproato de Hidroxiprogesterona inyectable, 250 mg/ml o vehículo, para la prevención del parto prema... | ||
Medical condition: Este es un estudio prospectivo, de seguimiento, diseñado para aportar una evaluación del desarrollo de niños nacidos de madres que participaron en el ensayo de eficacia de 17P | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) CZ (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000859-27 | Sponsor Protocol Number: HS_Apremilast | Start Date*: 2017-01-23 |
Sponsor Name:Erasmus University Medical Center | ||
Full Title: Efficacy and mode of action of apremilast (Otezla) in moderate hidradenitis suppurativa. An exploratory pilot study. | ||
Medical condition: Hidradenitis suppurativa, acne inversa, ectopic acne | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001340-19 | Sponsor Protocol Number: NLROW.1012.15 | Start Date*: 2016-07-21 |
Sponsor Name:Radboud University Medical Center | ||
Full Title: An uncontrolled, pilot-study assessing the efficacy of octreotide LAR to decrease transfusion requirements and endoscopy frequency in patients with Rendu-Osler-Weber and gastrointestinal bleeding | ||
Medical condition: Patients with Rendu-Osler-Weber disease (which is also called: Hereditary hemorrhagic telangiectasia) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004032-19 | Sponsor Protocol Number: NLOCEAN.505.14 | Start Date*: 2015-09-09 |
Sponsor Name:Radboud University Medical Center | ||
Full Title: A randomised, open-label clinical trial assessing the efficacy of octreotide to decrease iron infusion and blood transfusion requirements in patients with refractory anaemia due to gastrointestinal... | ||
Medical condition: small bowel angiodysplasias | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001987-28 | Sponsor Protocol Number: PRECOV | Start Date*: 2020-05-06 | ||||||||||||||||
Sponsor Name:OSPEDALE SAN RAFFAELE | ||||||||||||||||||
Full Title: PRECOV: a randomized controlled clinical trial on the effects of hydroxychloroquine in the prevention of COVID-19 in healthcare workers at risk | ||||||||||||||||||
Medical condition: Healthcare personnel at risk of SARS-CoV-2 infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-001870-32 | Sponsor Protocol Number: CDFV890D12201 | Start Date*: 2020-07-10 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: Phase 2, randomized, controlled, open label multi-center study to assess efficacy and safety of DFV890 for the treatment of SARS-CoV-2 infected patients with COVID-19 pneumonia and impaired respira... | |||||||||||||
Medical condition: COVID-19 pneumonia and impaired respiratory function | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) HU (Completed) DK (Completed) NL (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-003466-33 | Sponsor Protocol Number: 1103-011 | Start Date*: 2013-05-17 | |||||||||||
Sponsor Name:Mental Health Services North Holland North | |||||||||||||
Full Title: Memantine Add-On Therapy to Clozapine | |||||||||||||
Medical condition: Cognitive functioning, severity of psychopathology and treatment response (positive symptoms and negative symptoms of schizophrenia), depressive symptoms, social cognition, obsessive-compulsive sy... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-006315-68 | Sponsor Protocol Number: B3D-EW-GHDH | Start Date*: 2007-05-07 |
Sponsor Name:Eli Lilly and Company Limited | ||
Full Title: Comparison of the Effects of Teriparatide with those of Risendronate on Lumbar Spine Volumetric Bone Mineral Density in GLucocorticpid-Induced Osteoporosis in Men | ||
Medical condition: Males with glucocorticoid-induced osteoporosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: DE (Completed) GR (Completed) ES (Completed) IT (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-014696-52 | Sponsor Protocol Number: 17P-ES-003 | Start Date*: 2009-12-31 | |||||||||||
Sponsor Name:AMAG Pharma USA Inc. | |||||||||||||
Full Title: A PHASE 3B, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND STUDY OF HYDROXYPROGESTERONE CAPROATE INJECTION, 250 MG/ML, VERSUS VEHICLE FOR THE PREVENTION OF PRETERM BIRTH IN WOMEN WITH A PREVIOUS SINGLETON ... | |||||||||||||
Medical condition: Preterm birth | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: HU (Completed) ES (Completed) IT (Completed) CZ (Completed) BG (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-002741-18 | Sponsor Protocol Number: GS-US-611-6273 | Start Date*: 2022-11-25 | |||||||||||
Sponsor Name:Gilead Sciences, Inc. | |||||||||||||
Full Title: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GS-5245 for the Treatment of COVID-19 in Participants With High-Risk for Disease Progression | |||||||||||||
Medical condition: Coronavirus disease 2019 (COVID-19) in patients who have a high risk of developing serious or severe illness | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Completed) ES (Ongoing) BG (Completed) IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001364-27 | Sponsor Protocol Number: ZN-c5-001 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Zeno Alpha, Inc., | |||||||||||||
Full Title: A PHASE 1/2 OPEN LABEL, MULTICENTER STUDY TO ASSESS THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND ANTI-TUMOR ACTIVITY OF ZN-C5 ALONE AND IN COMBINATION WITH PALBOCICLIB IN SUBJECTS WITH ESTROGEN-... | |||||||||||||
Medical condition: Estrogen-receptor positive, human epidermal growth factor receptor-2 negative advanced breast cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) LT (Ongoing) BG (Prematurely Ended) HU (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.